EBRU DEMİRAY GÜRBÜZ

Dr. EBRU DEMİRAY GÜRBÜZ

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in World Journal of Gastroenterology
Verified
Journal Article
Open access
NANazlı Arslan
Nazlı Arslan
ÖYÖzlem Yılmaz
Özlem Yılmaz
EBRU DEMİRAY GÜRBÜZEBRU DEMİRAY GÜRBÜZ
EBRU DEMİRAY GÜRBÜZ
The management of Helicobacter pylori (H. pylori) infection treatment differs from the common treatment protocol for other infectious diseases. Because culture- or molecular-guided approaches face several practical issues, such as the invasive procedures required to obtain gastric biopsy specimens and the lack of availability of routine laboratory testing in some places, H. pylori treatment includes the administration of two or three empirically selected antibiotics combined with a proton pump inhibitor rather than evidence-based eradication treatment. The efficacy of empirical therapy is decreasing, mostly due to increasing multiple resistance. Multiresistance to levofloxacin, clarithromycin, and metronidazole, which are commonly used in empirical treatments, appears to have increased in many countries. Mutations play a primary role in the antimicrobial resistance of H. pylori, but many different mechanisms can be involved in the development of antibiotic resistance. Determining and understanding these possible mechanisms might allow the development of new methods for the detection of H. pylori and the determination of antimicrobial resistance. A treatment based on the detection of antimicrobial resistance is usually more effective than empirical treatment. Nevertheless, such an approach before treatment is still not recommended in the Maastricht guidelines due to the difficulty associated with the routine application of available culture- or molecular-based susceptibility tests, which are usually administered in cases of treatment failure. The management of first and rescue treatments requires further research due to the steadily increase in antimicrobial resistance.

8 August 2020 in International Journal Of Clinical Practice
Verified
Journal Article
Open access
PDF file
NKNesibe Korkmaz
Nesibe Korkmaz
SNSelçuk Nazik
Selçuk Nazik
RGRaziye Şule Gümüştakım
Raziye Şule Gümüştakım
HUHanife Uzar
Hanife Uzar
GKGülnur Kul
Gülnur Kul
HBHilal Bölükbaşı
Hilal Bölükbaşı
Aim Influenza vaccination is the most effective method in prevention of influenza disease and its complications. Our study aimed to investigate the rates of vaccination and the behaviors and attitudes against the vaccine in healthcare workers in Turkey. Methods This multicenter national survey is a descriptive study in which 12475 healthcare workers. Healthcare workers were asked to answer the questionnaire consisting of 12 questions via the survey. Results It was found that 6.7% of the healthcare workers regularly got vaccinated each year and that 55% had never had the influenza vaccine before. The biggest obstacle against getting vaccinated was determined as not believing in the necessity of the vaccine (53.1%). Conclusion The rates of influenza vaccination in healthcare workers in Turkey are quite low. False knowledge and attitudes on the vaccine and disease are seen as the most important reasons to decline vaccination. It is important to detect reasons for anti‐vaccination and set a course in order to increase the rates of vaccination.

1 April 2007 in Helicobacter
Verified
Journal Article
Closed access
PDF file
ÖYÖzlem Yilmaz
Özlem Yilmaz
EBRU DEMİRAY GÜRBÜZEBRU DEMİRAY GÜRBÜZ
EBRU DEMİRAY GÜRBÜZ
STSait Tümer
Sait Tümer
OAOǧuz Altungöz
Oǧuz Altungöz
KYKutsal Yörükoǧlu
Kutsal Yörükoǧlu
LŞLkay Şimşek
Lkay Şimşek

1 January 2006 in World Journal of Gastroenterology
Verified
Journal Article
Open access
EBRU DEMİRAY GÜRBÜZEBRU DEMİRAY GÜRBÜZ
EBRU DEMİRAY GÜRBÜZ
ÖYÖzlem Yılmaz
Özlem Yılmaz
CŞCihat Şarkış
Cihat Şarkış
MSMüjde Soytürk
Müjde Soytürk
IŞIlkay Şimşek
Ilkay Şimşek
Comparison of invasive methods and two different stool antigen tests for diagnosis of H pylori infection in patients with gastric bleeding

26 November 2016 in The Journal of Pathology: Clinical Research
Verified
Journal Article
Open access
PDF file
EBRU DEMİRAY GÜRBÜZEBRU DEMİRAY GÜRBÜZ
EBRU DEMİRAY GÜRBÜZ
ÖYÖzlem Yılmaz
Özlem Yılmaz
AOAsalia Z. Olivares
Asalia Z. Olivares
CGCan Gonen
Can Gonen
SSSülen Sarıoğlu
Sülen Sarıoğlu
Guillermo Perez PerezGuillermo Perez Perez
Guillermo Perez Perez
Helicobacter pylori remains one of the most common bacterial infections worldwide. Clarithromycin resistance is the most important cause of H. pylori eradication failures. Effective antibiotic therapies in H. pylori infection must be rapidly adapted to local resistance patterns. We investigated the prevalence of clarithromycin resistance due to mutations in positions 2142 and 2143 of 23SrRNA gene of H. pylori by fluorescence in situ hybridisation (FISH), and compared with culture and antimicrobial susceptibility testing in 234 adult patients with dyspepsia who were enrolled. Antrum and corpus biopsy specimens were obtained for rapid urease test, histopathology and culture. Epsilometer test was used to assess clarithromycin susceptibility. H. pylori presence and clarithromycin susceptibility were determined by FISH in paraffin‐embedded biopsy specimens. We found that 164 (70.1%) patients were positive for H. pylori based on clinical criteria, 114 (69.5% CI 62.5–76.6%) were culture positive, and 137 (83.5% CI 77.8–89.2%) were FISH positive. Thus the sensitivity of FISH was significantly superior to that of culture. However specificity was not significantly different (91.4 versus 100.0%, respectively). The resistance rate to clarithromycin for both antrum and corpus was detected in H. pylori‐positive patients; 20.2% by FISH and 28.0% by E‐test.The concordance between E‐test and FISH was only 89.5% due to the presence of point mutations different from A2143G, A2142G or A2142C. We conclude that FISH is significantly more sensitive than culture and the E‐test for the detection of H. pylori and for rapid determinination of claritromycin susceptibility. The superior hybridisation efficiency of FISH is becoming an emerging molecular tool as a reliable, rapid and sensitive method for the detection and visualisation of H. pylori, especially when the management of H. pylori eradication therapy is necessary. This is particularly important for the treatment of patients with H. pylori eradication failure.

14 August 2025
Verified
Journal Article
Open access
SOSeyda Silan Okalin
Seyda Silan Okalin
NANazli Arslan
Nazli Arslan
EBRU DEMİRAY GÜRBÜZEBRU DEMİRAY GÜRBÜZ
EBRU DEMİRAY GÜRBÜZ
MAMine Arayıcı
Mine Arayıcı
NKNevin Deniz Kırca
Nevin Deniz Kırca
AOAyse Aydan Ozkutuk
Ayse Aydan Ozkutuk
The human gut microbiota comprises approximately 100 trillion microbial cells and produces a wide range of metabolites. Its composition is shaped by factors such as geography, dietary habits, and genetic background. Dysbiosis-an imbalance in this microbial ecosystem-has been associated with the development of metabolic diseases. This study aimed to characterize the gut microbiota composition in adults without diagnosed chronic diseases and assess its potential associations with cardiometabolic parameters. Volunteers over the age of 18 residing in Izmir province who met the inclusion criteria were enrolled in the study. Fecal and blood samples were collected from all participants. Bacterial DNA from fecal samples was extracted, and the full-length 16 S rRNA was amplified. Full-length 16 S rRNA PCR amplicons were sequenced using Oxford Nanopore Technologies. Taxonomic classification, Firmicutes/Bacteroidetes ratio, and Shannon index were determined using Massbiome Fecal Microbiome Analysis (Massive Bioinformatics, Türkiye). Dominant bacterial genera were also analyzed using the Epi2Me database. Blood samples were analyzed for metabolic health markers. Associations between bacterial taxa and blood-based metabolic parameters were examined statistically. A total of 82 participants were included in the study. According to BMI, 34 (41.4%) of the participants were classified as having a healthy weight, 23 (28.1%) as overweight, and 25 (30.5%) as obese. Segatella (Prevotella) copri was identified as the dominant species in most participants (51%). Other dominant species included Ruminococcus torques (13%), Faecalibacterium prausnitzii (13%), Faecalitalea cylindroides (5%), Bacteroides uniformis (4%), and Phocaeicola vulgatus (3%). S. copri was identified as the dominant bacterial species in 45 participants (54.8%) according to the Epi2Me database. The Shannon index and Firmicutes/Bacteroidetes ratio varied among the three BMI groups. Both Lachnospira and Ruminococcus genera had a significant negative correlation with BMI, indicating that higher levels of BMI are associated with lower abundances of these genera. In the regression analysis, Lachnospira was found to be less abundant at higher HbA1c levels. HOMA-IR was found to be a significant predictor for the relative abundance of Vescimonas. Ruthenibacterium is found to be more abundant at higher HDL levels. The dominant bacterial taxa differed from those reported in other populations, suggesting region-specific microbial profiles. Notably, specific gut microbial genera were associated with metabolic health indicators, including BMI, HbA1c, HOMA-IR, and HDL level. These findings underscore the potential role of gut microbiota in metabolic regulation and support the need for further region-specific research. This study is among the few in Türkiye focusing on healthy adults and contributes to the understanding of gut microbiota in relation to cardiometabolic parameters.